TG Therapeutics, Inc. (TGTX)

27.53 -0.94 (-3.30%) USD  |  NASDAQ  |  Jan 12, 12:38
More

TG Therapeutics Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for TGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Amgen, Inc. --
Karyopharm Therapeutics, Inc. --
Axsome Therapeutics, Inc. --
Krystal Biotech, Inc. --
Arcutis Biotherapeutics, Inc. --